Replies to post #3980 on Entrex Carbon Market Inc (NTRX)

[DreamGreen]

This is from when he took over ETST back in 2013. I'm sure he has added more to his resume since then.

Doctor Issa El-Cheikh has over 25 years of experience in international finance, accounting, operations, business planning and sales. He has managed the financial operations of manufacturing concerns with up to 300 employees and $200 million in sales. Doctor Issa El-Cheikh has had significant experience including budgeting, planning and execution of large scale transitions in the public and private sectors. For the past 22 years Dr. Issa El-Cheikh has played a key role as a Vice-President in the automobile industry helping to execute large purchases, acquisitions, takeovers, as well as financial analysis and budgeting. For 4 years Doctor Issa El-Cheikh worked as a Vice President in Finance with Rosenau Power Sports and 17 years as a Vice President of Finance and controller for Auto Motive Group. Doctor Issa El-Cheikh worked for the United Nations for 6 years as a control officer and accounting aide from 1985 until 1991, Doctor Issa El-Cheikh has two master degrees in Accounting and finance and two PhD’s in accounting and finance.

[CJP123]

What could be the motive for buying RGLG?

Could RGLG be the clean shell that will be merged with ETST? Since Trisha Bollman was a consultant, I still have a feeling this could be a MJ/CBD related play - This short summary below reinforces my beliefs that this still could certainly be a MJ/CBD related company:

OMB, from that 10-Q you posted, it lays out the following regarding ETST:

Earth Science Tech, Inc. EST is a unique biotechnology company focused on cutting edge nutraceuticals and bioceuticals designed to excel in industries such as health, wellness, nutrition, supplement, cosmetic and alternative medicine to improve the quality of life for consumers worldwide. EST is dedicated in providing natural alternatives to prescription medications that help improve common disorders and illnesses. EST is focused on delivering nutritional and dietary supplements that help with treating symptoms such as: chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging and overall wellness. This may include products such as vitamins, minerals, herbs, botanicals, personal care products, homeopathics, functional foods, and other products. These products will be in various formulations and delivery forms including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs. Although, the Company has generated revenues it has incurred operating expenses and expenses associated with implementation of its business plan resulting in net operating losses for the reported periods and accumulated deficit since inception. The Company is devoting substantially all of its efforts on generating revenues from consulting services and implementation of its business plan.